Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neurosurgery

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006123-200007000-00041PMID 10917363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.

  2000cited by this paper
• Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

  2000cited by this paper
• Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors

  2000cited by this paper
• The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.

  1999cited by this paper
• Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.

  1999cited by this paper
• Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.

  1999cited by this paper
• Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

  1998cited by this paper
• Intra-arterial carboplatin chemotherapy for brain tumors: A dose escalation study based on cerebral blood flow

  1997cited by this paper
• Clinical studies with etoposide phosphate.

  1996cited by this paper
• Clinical studies with etoposide phosphate.

  1996cited by this paper
• Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

  1995cited by this paper
• Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.

  1995cited by this paper
• Advances in chemotherapy for brain tumors.

  1995cited by this paper
• Osmotic blood-brain barrier disruption: CT and radionuclide imaging.

  1994cited by this paper
• Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report.

  1994cited by this paper
• Phase I study of intracarotid administration of carboplatin.

  1992cited by this paper
• Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration.

  1991cited by this paper
• Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors

  1991cited by this paper
• Blood-Brain Barrier Disruption in the Treatment of Brain Tumors: Animal Studies

  1989cited by this paper
• Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.

  1986cited by this paper
• Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.

  1984cited by this paper

• Advancements in Using Polymeric Nanoparticles for Blood-Brain Barrier Penetration in Neurological Disorders.

  2025cites this paper
• Association between general anesthesia and contrast-induced encephalopathy after endovascular treatment on neurovascular diseases

  2023cites this paper
• Drug penetration in pediatric brain tumors: Challenges and opportunities

  2021cites this paper
• Pediatric sarcoma survivorship: A call for a developmental cascades approach

  2021cites this paper
• Blood-Brain Barrier Disruption Chemotherapy

  2020cites this paper
• Blood–Brain Barrier Disruption

  2019cites this paper
• Pharmacokinetics of Drug Delivery Past the Blood–Brain Barrier

  2019cites this paper
• 20 Strategies in Glioma-Surgery

  2018cites this paper
• Assessment of drug-loaded nanoparticles in a 3D in vitro brain tumour model

  2015cites this paper
• Osmotic Opening of the BBB for Drug Treatment of Brain Tumors (Focus on Methodological Issues)

  2014cites this paper
• Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.

  2014cites this paper
• PCNSL primary central nervous system lymphoma PFS progression-free survival PNET primitive neuroectodermal tumor

  2014cites this paper
• Multiplexing Spheroid Volume, Resazurin and Acid Phosphatase Viability Assays for High-Throughput Screening of Tumour Spheroids and Stem Cell Neurospheres

  2014cites this paper
• Impact of Drug Size on Brain Tumor and Brain Parenchyma Delivery after a Blood–Brain Barrier Disruption

  2014cites this paper
• A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.

  2012cites this paper
• Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.

  2012cites this paper
• Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development

  2011cites this paper
• Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol.

  2011cites this paper
• Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide‐induced DNA damage

  2011cites this paper
• Blood-brain barrier disruption in the treatment of brain tumors.

  2011cites this paper
• Strategies in Glioma-Surgery

  2011cites this paper
• Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy

  2008cites this paper
• La barrière hémato-encéphalique : un facteur clé en Neuro-oncologie

  2004cites this paper
• [The blood-brain barrier should not be underestimated in neuro-oncology].

  2004cites this paper
• Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability

  2004cites this paper
• A Blood-Brain Barrier Disruption Model Eliminating the Hemodynamic Effect of Ketamine

  2004cites this paper
• Defining the Appropriate Dosage of Folinic Acid After High-Dose Methotrexate for Childhood Acute Lymphatic Leukemia That Will Prevent Neurotoxicity Without Rescuing Malignant Cells in the Central Nervous System

  2004cites this paper
• Sleep disruption in critically ill patients – pharmacological considerations

  2004cites this paper
• Altering the properties of the blood-brain barrier: disruption and permeabilization.

  2003cites this paper
• The effect of infusions of adrenaline, noradrenaline and dopamine on cerebral autoregulation under propofol anaesthesia in an ovine model

  2003cites this paper
• Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.

  2003cites this paper
• The Cerebrovascular Effects of Adrenaline, Noradrenaline and Dopamine Infusions under Propofol and Isoflurane Anaesthesia in Sheep

  2002cites this paper